A clinical study to evaluate the effectiveness of Ksharapippali and Mahodarahara Kashaya in Vatashteela w.s.r to BPH

A comparative clinical study to evaluate the efficacy of Ksharapippali and Mahodarahara kashaya in Vatashteela with special reference to Benign Prostatic Hyperplasia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054658

Enrollment

Registered

2023-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject with signs and symptoms of Vatashteela (BPH). 2.Subject with mild to moderate BPH with score 1-19, as per The International Prostate Symptom Score index.

Exclusion criteria

Exclusion criteria: 1.Subject with malignancy. 2.Subject more than 80 years of age. 3.Subject with severe cardio vascular, Renal or Hepatic disorders, uncontrolled Hypertension & Diabetes mellitus. 4.Subjects with immune compromised diseases. 5.Subject with USG findings suggestive of severe Hydroureteronephrosis. 6.Post-void Residual urine volume more than 100ml as assessed by USG of Abdomen and pelvis

Design outcomes

Primary

Measure	Time frame
Reduction in lower urinary tract symptomsTimepoint: 28 days	—

Secondary

Measure	Time frame
Decrease in post void residual urine volume & reduction in enlargement of prostateTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Srinivas Masalekar

Sri Jayachamarajendra Government Ayurveda and Unani Hospital Bengaluru

masalekar@gmail.com9886632966

Outcome results